Mr. Cummings has 20 years of experience in the pharmaceutical industry, initially working with a large pharmaceutical company, and for the past 17 years has resided on the consulting side of the business. He is well-versed in all qualitative and quantitative methods, and has specific therapeutic category expertise in gastrointestinal disease, oncology, CNS, respiratory and vaccines. For much of his career, he has focused on developing pharmaceutical brand strategies and promotional platforms, which makes him an invaluable resource for clients needing help with their product positioning and messaging. In the last decade, Mr. Cummings has also devoted much of his efforts toward the identification and development of new product opportunities utilizing his therapeutic area expertise and several of Evolution’s proprietary early-development methodologies. In addition, Mr. Cummings conducts a great deal of research aimed at informing the design of pivotal Phase III clinical trials. Across all qualitative methodologies, he is valued by clients as a very skilled moderator.
Mr. Cummings earned his Masters of Arts from the University of Delaware. He is a married father of 3 children and resides in Doylestown, PA.